Follicular Thyroid Cancer Overview

Save information for later
Sign Up

Learn About Follicular Thyroid Cancer

View Main Condition: Thyroid Cancer

What is the definition of Follicular Thyroid Cancer?
Follicular thyroid cancer is a cancer that forms from the follicular cells of the thyroid and is the second most common type of thyroid cancer. It is more common in females. It usually affects people between the ages of 40 and 60 and can be an aggressive disease, as it characteristically invades blood vessels and spreads (metastasizes) to other parts of the body. A sub-type, Hurthle cell cancer, is a rare, more aggressive type of follicular thyroid cancer. While the exact cause is unclear, thyroid cancer develops when genetic mutations occur in thyroid cells that then reproduce rapidly, form a tumor, and spread to other areas, such as lung, bone, brain, liver, bladder, and skin.
What are the symptoms of Follicular Thyroid Cancer?
Since individuals with follicular thyroid cancer can have no symptoms, the cancer is usually found during routine examination with the discovery of a neck mass or nodule, or after having an X-ray of the neck for another reason, or during other medical and/or diagnostic treatments. However, for individuals who do experience symptoms of follicular thyroid cancer, these symptoms can include a large, malignant neck mass more than 4 cm, a fixed mass, soft tissue invasion, vocal cord paralysis, and difficulty swallowing.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Follicular Thyroid Cancer?
Treatments for follicular thyroid cancer depend on the mass and include hemi-thyroidectomy (partial removal of thyroid) and removal of the thyroid isthmus, or total thyroidectomy and the removal of neck lymph nodes. After surgery, patients may be placed on thyroid hormone replacement and should have the usual cancer care follow-up. The overall cure rate for follicular thyroid cancer is nearly 95% for small tumors in young patients; however, this rate decreases with age. If follicular thyroid cancer is treated early, it has a good prognosis.
Who are the top Follicular Thyroid Cancer Local Doctors?
Elite in Follicular Thyroid Cancer
Dr. Ian S. Ganly
Otolaryngology
Elite in Follicular Thyroid Cancer
Dr. Ian S. Ganly
Otolaryngology

Mskcc Surgery Group

1133 York Ave, 
New York, NY 
646-888-7100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ian Ganly is an Otolaryngologist in New York, New York. Dr. Ganly is rated as an Elite provider by MediFind in the treatment of Follicular Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Tongue Cancer, Thyroidectomy, and Laryngectomy.

Elite in Follicular Thyroid Cancer
Dr. Mark E. Zafereo
Otolaryngology
Elite in Follicular Thyroid Cancer
Dr. Mark E. Zafereo
Otolaryngology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
713-592-5433
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Zafereo is an Otolaryngologist in Houston, Texas. Dr. Zafereo is rated as an Elite provider by MediFind in the treatment of Follicular Thyroid Cancer. His top areas of expertise are Anaplastic Thyroid Cancer, Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Laryngectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Follicular Thyroid Cancer
Dr. Robert M. Tuttle
Endocrinology
Elite in Follicular Thyroid Cancer
Dr. Robert M. Tuttle
Endocrinology

Memorial Endocrine Group

1275 York Ave, 
New York, NY 
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Robert Tuttle is an Endocrinologist in New York, New York. Dr. Tuttle is rated as an Elite provider by MediFind in the treatment of Follicular Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, Thyroidectomy, and Gastrostomy.

View All Doctors
What are the latest Follicular Thyroid Cancer Clinical Trials?
Studies on Thyroid Nodules and Thyroid Cancer
Studies on Thyroid Nodules and Thyroid Cancer
Enrollment Status: Recruiting
Publish Date: September 29, 2025
Intervention Type: Drug

Summary: Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Ot...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy
Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy
Enrollment Status: Recruiting
Publish Date: March 17, 2025

Summary: Thyroid cancer (TC) is the most common endocrine malignancy, with well-differentiated thyroid carcinomas (DTCs)-papillary (PTC) and follicular (FTC)-comprising the majority of cases. While DTCs generally have favorable prognoses, a subset progresses to poorly differentiated or anaplastic thyroid carcinoma (ATC), which is highly aggressive. Tumor classification is based on histopathology, invasiven...

View All Clinical Trials
What are the Latest Advances for Follicular Thyroid Cancer?
An unusual presentation of metastatic thyroid carcinoma.
An unusual presentation of metastatic thyroid carcinoma.
Journal: South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie
Published: October 07, 2025
USP7 promotes follicular thyroid carcinoma progression and sorafenib resistance by activating NEK2/ATG5-mediated autophagy.
USP7 promotes follicular thyroid carcinoma progression and sorafenib resistance by activating NEK2/ATG5-mediated autophagy.
Journal: Histology and histopathology
Published: August 21, 2025
Tired of the same old research?
Check Latest Advances
Thermal ablation versus surgical resection for follicular thyroid neoplasm: a multicenter study.
Thermal ablation versus surgical resection for follicular thyroid neoplasm: a multicenter study.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: August 07, 2025
View All Latest Advances